VERBEECK, Johan

Email Alert RSS Feed

Profile

Full Name
VERBEECK, Johan
Email
johan.verbeeck@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 1-20 of 43 (Search time: 0.001 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
12025From non-inferiority to superiority: the shift towards patient-centric outcomesVERBEECK, Johan; De Backer, Mickael; BUYSE, MarcJournal ContributionA2
22025Reflection on clinical and methodological issues in rare disease clinical trialsVERBEECK, Johan; Geroldinger, Martin; Nyberg, Joakim; Thiel, Konstantin E.; Hooker, Andrew C.; Bathke, Arne C.; Bauer, Johann W.; Laimer, Martin; MOLENBERGHS, Geert; Zimmermann, GeorgJournal ContributionA1
32025Dravet syndrome: Insights into seizure and speech progression from registry dataDelporte, Margaux; VERBEECK, Johan; Brambilla, Isabella; Zimmermann, Georg; MOLENBERGHS, Geert; Nabbout, RimaJournal ContributionA1
42025Utilising the Benefit Risk Assessment of Vaccines (BRAVE) toolkit to evaluate the benefits and risks of Vaxzevria in the EU: a population-based studyGonzalez Dorta, Hector; VERBEECK, Johan; CREVECOEUR, Jonas; Morales, Daniel; LOEDY, Neil; Cohet, Catherine; Willem , Lander; MOLENBERGHS, Geert; HENS, Niel; Kurz, Xavier; Quinten, Chantal; ABRAMS, StevenJournal ContributionA1
52025Effect of targeted education of patients with atrial fibrillation on unplanned cardiovascular outcomes: results of the multicentre randomized AF-EduCare trialDESTEGHE, Lien; DELESIE, Michiel; KNAEPEN, Lieselotte; ONDER, Rana; VERBEECK, Johan; DENDALE, Paul; Phlips, Thomas; Saenen, Johan; Haemers , Peter; Ector, Joris; VIJGEN, Johan; HEIDBUCHEL, HeinJournal ContributionA1
62025An extension of the Benefit Risk Assessment of VaccinEs toolkit to evaluate Comirnaty and Spikevax vaccination in the European UnionLOEDY, Neil; Dorta, Hector G.; ABRAMS, Steven; CREVECOEUR, Jonas; Morales, Daniel R.; Cohet, Catherine; WILLEM, Lander; MOLENBERGHS, Geert; HENS, Niel; Kurz, Xavier; Quinten, Chantal; VERBEECK, JohanJournal ContributionA1
72024Covariate-adjusted generalized pairwise comparisons in small samplesJASPERS, Stijn; VERBEECK, Johan; THAS, OlivierJournal ContributionA1
82024Rethinking survival analysis: advancing beyond the hazard ratio?VERBEECK, Johan; Saad, Everardo D.Journal ContributionA1
92024Optimizing designs in clinical trials with an application in treatment of Epidermolysis bullosa simplex, a rare genetic skin diseaseNyberg, Joakim; Hooker, Andrew C.; Zimmermann, Georg; VERBEECK, Johan; Geroldinger, Martin; Thiel, Konstantin Emil; Laimer, Martin; MOLENBERGHS, Geert; Wally, VerenaJournal ContributionA1
102024Multi-stakeholder sessions on major innovation topics in rare disease clinical trialsBodden, Daniel; Schoenen, Stefanie; Wied, Stephanie; VERBEECK, Johan; Dirani, Maya; Daya, Hiba Abou; Heussen, Nicole; MOLENBERGHS, Geert; Hilgers, Ralf-Dieter; Nabbout, RimaJournal ContributionA1
112024Acoramidis in Transthyretin Amyloid CardiomyopathyVERBEECK, Johan; De Backer, Mickael; BUYSE, MarcJournal ContributionA1
122024The impact of allocation bias on test decisions in clinical trials with multiple endpoints using multiple testing strategiesSchoenen, Stefanie; Heussen, Nicole; VERBEECK, Johan; Hilgers, Ralf-DieterJournal ContributionA1
132024Unraveling the impact of the COVID-19 pandemic on the mortality trends in Belgium between 2020-2022NATALIA, Yessika; VERBEECK, Johan; FAES, Christel; NEYENS, Thomas; MOLENBERGHS, GeertJournal ContributionA1
142024Istore: a project on innovative statistical methodologies to improve rare diseases clinical trials in limited populationsSchoenen, Stefanie; VERBEECK, Johan; Koletzko, Lukas; Brambilla, Isabella; Kuchenbuch, Mathieu; Dirani, Maya; Zimmermann, Georg; Dette, Holger; Hilgers, Ralf-Dieter; MOLENBERGHS, Geert; Nabbout, RimaJournal ContributionA1
152024Evaluating the direct effect of vaccination and non-pharmaceutical interventions during the COVID-19 pandemic in EuropeFAJGENBLAT, Maxime; MOLENBERGHS, Geert; VERBEECK, Johan; WILLEM, Lander; CREVECOEUR, Jonas; FAES, Christel; HENS, Niel; Deboosere, Patrick; VERBEKE, Geert; NEYENS, ThomasJournal ContributionA1
162024Enhancing robustness in acute cardiovascular observational studies: evaluating covariate adjustmentVERBEECK, JohanJournal ContributionA1
172023Win statistics (win ratio, win odds, and net benefit) can complement one another to show the strength of the treatment effect on time-to-event outcomesDong, Gaohong; Huang, Bo; VERBEECK, Johan; Cui, Ying; Song, James; Gamalo‐siebers, Margaret; Wang, Duolao; Hoaglin, David; Seifu, Yodit; Mütze, Tobias; Kolassa, JohnJournal ContributionA1
182023Comparing COVID-19 incidences longitudinally per economic sector against the background of preventive measures and vaccinationStijven, Florian; VERBEECK, Johan; MOLENBERGHS, GeertJournal ContributionA1
192023Generalized Pairwise Comparisons to Assess Treatment Effects: JACC Review Topic of the WeekVERBEECK, Johan; De Backer, Mickael; VERWERFT, Jan; Salvaggio, Samuel; Valgimigli, Marco; VRANCKX, Pascal; BUYSE, Marc; Brunner, EdgarJournal ContributionA1
202023Composite endpoints, including patient reported outcomes, in rare diseasesVERBEECK, Johan; Dirani, Maya; Bauer, Johann W.; Hilgers, Ralf-Dieter; MOLENBERGHS, Geert; Nabbout, RimaJournal ContributionA1
show all